Good morning :)
$
Haleon plc

Haleon plc

HLN

NYSE
$9.970.96% (+0.09)
High
Low
Returns
1D
1W
1M
1Y
5Y
Max
Loading...
1D
1W
1M
1Y
5Y
Max

Healthcare

Drug Manufacturers - Specialty & Generic

Large Cap

With a market cap of $44.2B the stock is ranked 676

Key Metrics

Key Metrics

PE TTM
PE TTM

Close price divided by the earnings per share for the trailing twelve months

20.24
PB
PB

Close price divided by the book value per share at the end of the most recent quarter

2.03
EPS TTM
EPS TTM

Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)

$0.49
PEG Ratio
PEG Ratio

Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years

2.64
Profit Margin
Profit Margin

Net profit divided by the total revenue for the most recent financial year

15.11%
Dividend Yield
Dividend Yield

Annual dividend per share for the trailing twelve months divided by the close price

0.72%

Analyst Ratings & Forecast
Analyst Ratings & Forecast

Based on 5 analysts' reports

Buy
4 analysts
Hold
0 analyst
Sell
1 analyst

Analysts expect a +22.14% price upside over the next year

Current Price$9.97
Target Price$12.06

Company Profile

Peers

Peers

P/E Ratio
87.58
87.58
1Y Return
13.42%
13.42%
Buy Reco %
57.14
57.14
P/E Ratio
24.07
24.07
1Y Return
20.21%
20.21%
Buy Reco %
46.87
46.87
P/E Ratio
20.66
20.66
1Y Return
33.39%
33.39%
Buy Reco %
63.33
63.33
P/E Ratio
28.36
28.36
1Y Return
6.02%
6.02%
Buy Reco %
52.94
52.94
P/E Ratio
18.41
18.41
1Y Return
39.87%
39.87%
Buy Reco %
76.00
76.00

Peers & Comparison

Peers & Comparison

Comparing 2 stocks from
HealthcareDrug Manufacturers - Specialty & Generic
StockPE TTMPE TTMPBPBPEG RatioPEG Ratio
Haleon plc 20.242.032.64
AbbVie Inc87.5850.450.49
Amgen Inc24.0721.662.33

Price Comparison

Price Comparison

1 Month

1 Year

5 Years

Loading...

Financials

Financials

Income

Balance Sheet

Cash Flow

5.5
0.7
2.7
0.4
5.4
0.8
5.5
0.8
Q4 2024
Q1 2025
Q2 2025
Q4 2025
Revenue
Net Income
Financial YearQ2 2023Q3 2023Q4 2023Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q4 2025
Total Revenue5.732.795.562.915.692.785.532.745.485.51
Net Income0.680.360.360.420.720.480.710.400.800.85
Net Profit Margin11.97%13.04%6.50%14.49%12.75%17.44%12.92%14.70%14.70%15.51%
Loading...